Could a puff of air improve the TB vaccine? oxford study tests new approach
NCT ID NCT06246851
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests whether giving the BCG vaccine as an inhaled mist works better than the usual injection for boosting immunity against tuberculosis. It includes 36 healthy adults who have already had the BCG vaccine, some with type 2 diabetes and some without. Researchers will measure immune responses through blood tests and a lung wash procedure 14 days after vaccination.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Clinical Vaccinology and Tropical Medicine
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.